U.S. drugmaker Biogen Inc. is investing more than $92 million in Puerto Rico after buying assets that once belonged to Eli Lilly & Co. in the island’s southern region.
Gov. Alejandro Garcia Padilla says the Massachusetts-based company will manufacture active pharmaceutical ingredients at the plant in Guayama and employ about350 people in the next five years.
Garcia said Monday that his administration offered about $2 million worth of incentives as part of the deal.
An increasing number of health care companies are investing in Puerto Rico as the U.S. territory seeks to boost its manufacturing sector amid a 10-year economic slump.
Source: The Associated Press via The Washington Post
The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens Soerensen, Professor and Clinical Advisor to MedTrace, are the originators of the method.
Teresa Graham, currently head of global product strategy for Roche pharma, will become the division’s new CEO next month, Roche said Thursday. Simultaneously, Roche is elevating Levi Garraway, chief medical officer, to the executive committee.
Fierce Pharma has obtained internal documents and video of a town hall meeting conducted this week describing what J&J called a “comprehensive review” of its portfolio. Moving forward, J&J plans to operate its vaccines and infectious diseases outfits as one group, the executives explained.
